China’s National Medical Products Administration (NMPA) granted new approvals to several Chinese biopharmaceuticals this week, including expanding indications of four different cancer drugs and ...
Hutchmed China's Elunate formula contains fruquintinib, while Innovent developed the Sintilimab injection with TYVYT. The combined formula has been approved for use in patients with advanced ...